Background
EVENT, STAGGERED
Nen ŨnkUmbi/EdaHiYedo (“We Are Here Now,” or There is now a growing body of literature concerning the impact of COVID-19 on clinical trials [The COVID-19 pandemic was an unexpected, exogenous factor that could affect numerous aspects of an ongoing SWD trial, including secular trends in the primary outcome. SWD trials experience risks of bias attributable to secular trends that are not specified in the analytic stage. The staggered rollout period may occur during a time in which an exogenous factor or event significantly impacts the outcome and/or sample and may partially confound the estimated effect of the intervention. In addition, SWD trials with a small number of heterogeneous clusters may experience added risk for secular trends that are easy to miss during the analytic stage [This current study focuses on sexual and reproductive health outcomes that may have been affected by the COVID-19 pandemic during a SWD trial. To evaluate 